Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Uniqure NV (NASDAQ:QURE)

15.49
Delayed Data
As of Feb 05
 -1.08 / -6.52%
Today’s Change
13.27
Today|||52-Week Range
36.38
-6.35%
Year-to-Date
No recent news for Uniqure NV.

Today’s Trading

Previous close16.57
Today’s open16.50
Day’s range15.47 - 16.52
Volume265,806
Average volume (3 months)402,439
Market cap$45.7M
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)-41.98%
Earnings growth (this year)--
Earnings growth (next 5 years)-26.60%
Revenue growth (last year)+59.05%
P/E ratio--
Price/Sales40.80
Price/Book5.37

Competitors

 Today’s
change
Today’s
% change
VBIVVBI Vaccines Inc-0.16-7.55%
ORPNBio Blast Pharma Ltd+0.02+0.66%
VSTMVerastem Inc-0.06-5.04%
FATEFate Therapeutics In...0.000.00%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateMarch 23, 2016
EPS forecast (this quarter)-$0.69
Annual revenue (last year)$6.2M
Annual profit (last year)-$49.1M
Net profit margin-790.61%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Daniel B. Soland
Chief Operating Officer
Eric Goossens
Corporate headquarters
Amsterdam, Noord-holland

Forecasts

Partner Offers